Anodyne Nanotech

Developing transdermal therapeutics for chronic care.

Biotechnology 📍 Boston, MA

Current Valuation

Private

PRIVATE

Developing transdermal therapeutics for chronic care. Headquartered in Boston, MA. Raised $12.6M in Series A funding in June 2026 led by Velocity Partners VC.

Company Profile

CEO

Jake Lombardo

Boston, MA

Total Raised

$12.6M

Last Round

Series A — $12.6M (Jun 2026) · Lead: Velocity Partners VC

IPO Status

private

Fundraising Status

Series A · $12.6M · 2 mo ago

privateTotal raised $12.6M1 disclosed rounds

Funding History

Round	Amount	Date	Lead Investor	Post-Money
Series A	$12.6M	Jun 2026	Velocity Partners VC	—

Investors

Velocity Partners VC · Evercurious VC · Relativity Healthcare Partners

BiotechnologyClinical-stage BiotechRecently Funded

Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.